EBioMedicine,
Journal Year:
2024,
Volume and Issue:
106, P. 105229 - 105229
Published: July 5, 2024
Cerebral
palsy
(CP)
has
historically
been
attributed
to
acquired
insults,
but
emerging
research
suggests
that
genetic
variations
are
also
important
causes
of
CP.
While
microarray
and
whole-exome
sequencing
based
studies
have
the
primary
methods
for
establishing
new
CP-gene
relationships
providing
a
etiology
individual
patients,
cause
their
condition
remains
unknown
many
patients
with
Recent
advancements
in
genomic
technologies
offer
additional
opportunities
uncover
human
genomes,
transcriptomes,
epigenomes
previously
escaped
detection.
In
this
review,
we
outline
use
these
state-of-the-art
address
molecular
diagnostic
challenges
experienced
by
individuals
We
explore
importance
identifying
whenever
possible,
given
potential
medicine
provide
treat
CP
more
precise
ways.
Genome Medicine,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Nov. 9, 2023
Abstract
Background
Whole
genome
sequencing
is
increasingly
being
used
for
the
diagnosis
of
patients
with
rare
diseases.
However,
diagnostic
yields
many
studies,
particularly
those
conducted
in
a
healthcare
setting,
are
often
disappointingly
low,
at
25–30%.
This
part
because
although
entire
genomes
sequenced,
analysis
confined
to
silico
gene
panels
or
coding
regions
genome.
Methods
We
undertook
WGS
on
cohort
122
unrelated
disease
and
their
relatives
(300
genomes)
who
had
been
pre-screened
by
arrays.
Patients
were
recruited
from
broad
spectrum
clinical
specialties.
applied
bioinformatics
pipeline
that
would
allow
comprehensive
all
variant
types.
combined
established
tools
phenotypic
genomic
our
novel
algorithms
(SVRare,
ALTSPLICE
GREEN-DB)
detect
annotate
structural,
splice
site
non-coding
variants.
Results
Our
yield
was
43/122
cases
(35%),
47/122
(39%)
considered
solved
when
considering
candidate
genes
supporting
functional
data
into
account.
Structural,
deep
intronic
variants
contributed
20/47
(43%)
cases.
Five
novel,
time
discovery,
identified,
whilst
further
three
putative
evidence
causality.
identified
uncertain
significance
fourteen
genes.
The
associated
RMND1
expanded
include
polymicrogyria.
Two
secondary
findings
FBN1
KCNQ1
confirmed
have
previously
unidentified
Marfan
long
QT
syndromes,
respectively,
referred
interventions.
Clinical
diagnoses
changed
six
treatment
adjustments
made
eight
individuals,
which
five
life-saving.
Conclusions
Genome
as
first-line
genetic
test
routine
settings
can
make
substantial
contribution
rapidly
identifying
causal
aetiology
patients,
shortening
odyssey.
demonstrated
significant
essential
maximise
value
sequencing.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 9, 2024
Abstract
E3
ubiquitin
protein
ligase
encoded
by
ARIH2
gene
catalyses
the
ubiquitination
of
target
proteins
and
plays
a
crucial
role
in
posttranslational
modifications
across
various
cellular
processes.
As
prior
documented,
mutations
genes
involved
process
are
often
associated
with
autism
spectrum
disorder
(ASD)
and/or
intellectual
disability
(ID).
In
current
study,
de
novo
heterozygous
mutation
was
identified
splicing
intronic
region
adjacent
to
last
exon
using
whole
exome
sequencing
(WES).
We
hypothesize
that
this
mutation,
found
an
ASD/ID
patient,
disrupts
Ariadne
domain
which
is
autoinhibition
enzyme.
Predictive
analyses
elucidated
implications
novel
confirmed
its
autosomal
dominant
inheritance
model.
Nevertheless,
we
cannot
exclude
possibility
other
genetic
factors,
undetectable
WES,
such
as
non-coding
regions
polygenic
risk
inter-allelic
complementation,
may
contribute
patient's
phenotype.
This
work
aims
suggest
potential
relationship
between
detected
both
ASD
ID,
even
though
functional
studies
combined
new
approaches
will
be
necessary
validate
hypothesis.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1201 - 1201
Published: Jan. 18, 2024
Cancer
stands
as
the
leading
global
cause
of
mortality,
with
rare
cancer
comprising
230
distinct
subtypes
characterized
by
infrequent
incidence.
Despite
inherent
challenges
in
addressing
diagnosis
and
treatment
cancers
due
to
their
low
occurrence
rates,
several
biomedical
breakthroughs
have
led
significant
advancement
both
areas.
This
review
provides
a
comprehensive
overview
state-of-the-art
diagnostic
techniques
that
encompass
new-generation
sequencing
multi-omics,
coupled
integration
artificial
intelligence
machine
learning,
revolutionized
diagnosis.
In
addition,
this
highlights
latest
innovations
therapeutic
options,
immunotherapy,
targeted
therapy,
transplantation,
drug
combination
undergone
clinical
trials
significantly
contribute
tumor
remission
overall
survival
patients.
review,
we
summarize
recent
insights
understanding
pathophysiology,
diagnosis,
modalities,
well
faced
development
data
interpretation
development.
Journal of Clinical Immunology,
Journal Year:
2024,
Volume and Issue:
44(3)
Published: March 8, 2024
Abstract
Congenital
athymia
is
a
rare
T-lymphocytopaenic
condition,
which
requires
early
corrective
treatment
with
thymus
transplantation
(TT).
Athymic
patients
are
increasingly
identified
through
newborn
screening
(NBS)
for
severe
combined
immunodeficiency
(SCID).
Lack
of
relatable
information
resources
contributes
to
challenging
patient
and
family
journeys
during
the
diagnostic
period
following
abnormal
NBS
results.
Patient
Public
Involvement
Engagement
(PPIE)
activities,
including
parental
involvement
in
paediatrics,
valuable
initiatives
improve
clinical
communication
strategies.
Parents
infants
suspected
were
therefore
invited
discuss
they
received
aim
identify
needs
targeted
strategies
address
these
adequately.
reported
that
was
not
considered
them
as
possible
differential
diagnosis
until
weeks
after
initial
Whilst
appropriate
about
TT
available
upon
referral
specialist
immunology
services,
improved
access
easy-to-understand
from
reliable
sources,
nurse
specialists
peer
support
systems,
remained
desirable.
A
roadmap
concept,
written
or
digital
information,
addressing
real
time
potentially
complex
journey,
proposed
transferrable
other
inborn
errors
immunity
(IEI)
diseases.
This
PPIE
activity
provides
insight
into
parents
who
SCID
NBS,
highlights
role
promoting
patient-
family-centred
IEI
care.
Practical Neurology,
Journal Year:
2024,
Volume and Issue:
24(4), P. 263 - 274
Published: March 28, 2024
Whole-genome
sequencing
(WGS)
has
recently
become
the
first-line
genetic
investigation
for
many
suspected
neurological
disorders.
While
its
diagnostic
capabilities
are
innumerable,
as
with
any
test,
it
limitations.
Clinicians
should
be
aware
of
where
WGS
is
extremely
reliable
(detecting
single-nucleotide
variants),
reliability
much
improved
copy
number
variants
and
small
repeat
expansions)
may
miss/misinterpret
a
variant
(large
expansions,
balanced
structural
or
low
heteroplasmy
mitochondrial
DNA
variants).
Bioinformatic
technology
virtual
gene
panels
constantly
evolving,
important
to
know
what
genes
types
being
tested;
current
National
Health
Service
Genomic
Medicine
offers
more
than
early
iterations
100
000
Genomes
Project
analysis.
Close
communication
between
clinician
laboratory,
ideally
through
multidisciplinary
team
meeting,
encouraged
there
uncertainty.
npj Genomic Medicine,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Feb. 28, 2025
Genetic
testing
is
essential
for
diagnosing
and
managing
clinical
conditions,
particularly
rare
Mendelian
diseases.
Although
efforts
to
identify
phenotype-associated
variants
have
focused
on
protein-truncating
variants,
interpreting
missense
remains
challenging.
Deep
learning
algorithms
excel
in
various
biomedical
tasks1,2,
yet
distinguishing
pathogenic
from
benign
elusive3–5.
Our
investigation
of
AlphaMissense
(AM)5,
a
deep
tool
predicting
the
potential
functional
impact
assessing
gene
essentiality,
reveals
limitations
identifying
over
45
diseases,
including
very
early
onset
inflammatory
bowel
disease.
For
expert-curated
identified
our
cohort,
AM's
precision
was
32.9%,
recall
57.6%.
Notably,
AM
struggles
evaluate
pathogenicity
intrinsically
disordered
regions
(IDRs),
resulting
unreliable
gene-level
essentiality
scores
genes
containing
IDRs.
This
observation
underscores
ongoing
challenges
genetics,
highlighting
need
continued
refinement
computational
methods
variant
prediction.
Genomics & Informatics,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 6, 2025
Large-scale
national
biobank
projects
utilizing
whole-genome
sequencing
have
emerged
as
transformative
resources
for
understanding
human
genetic
variation
and
its
relationship
to
health
disease.
These
initiatives,
which
include
the
UK
Biobank,
All
of
Us
Research
Program,
Singapore's
PRECISE,
Biobank
Japan,
National
Project
Bio-Big
Data
Korea,
are
generating
unprecedented
volumes
high-resolution
genomic
data
integrated
with
comprehensive
phenotypic,
environmental,
clinical
information.
This
review
examines
methodologies,
contributions,
challenges
major
WGS-based
genome
worldwide.
We
first
discuss
landscape
highlighting
their
distinct
approaches
collection,
participant
recruitment,
phenotype
characterization.
then
introduce
recent
technological
advances
that
enable
efficient
processing
analysis
large-scale
WGS
data,
including
improvements
in
variant
calling
algorithms,
innovative
methods
creating
multi-sample
VCFs,
optimized
storage
formats,
cloud-based
computing
solutions.
The
synthesizes
key
discoveries
from
these
projects,
particularly
identifying
expression
quantitative
trait
loci
rare
variants
associated
complex
diseases.
Our
introduces
latest
findings
has
advanced
our
population-specific
diseases
Korean
East
Asian
populations.
Finally,
we
future
directions
maximizing
impact
on
precision
medicine
global
equity.
examination
demonstrates
how
revolutionizing
research
healthcare
delivery
while
importance
continued
investment
diverse,
resources.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 10, 2025
Abstract
Prostate
cancer
(PCa)
is
highly
heritable,
with
men
of
African
ancestry
at
greatest
risk
and
associated
lethality.
Lack
representation
in
genomic
data
means
germline
testing
guidelines
exclude
for
Africans.
Established
that
structural
variations
(SVs)
are
major
contributors
to
human
disease
prostate
tumourigenesis,
their
role
under-appreciated
familial
therapeutic
testing.
Utilising
clinico-methodologically
matched
deep-sequenced
whole-genome
113
versus
57
European
PCa
patients,
we
interrogate
42,966
high-quality
SVs
using
a
best-fit
pathogenicity
prediction
workflow.
We
identify
15
potentially
pathogenic
representing
12.4%
7.0%
which
72%
86%
met
standard-of-care
recommendations,
respectively.
Notable
African-specific
loss-of-function
gene
candidates
include
DNA
damage
repair
MLH1
BARD1
tumour
suppressors
FOXP1,
WASF1
RB1
.
Representing
only
fraction
the
vast
diaspora,
this
study
raises
considerations
respect
contribution
kilo-to-mega-base
rare
variants
African-associated
disparity.
npj Genomic Medicine,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: March 21, 2025
Individuals
with
heritable
thoracic
aortic
disease
(HTAD)
face
a
high
risk
of
deadly
dissections,
but
genetic
testing
identifies
causative
variants
in
only
minority
cases.
We
explored
the
contribution
non-canonical
splice
(NCVAS)
to
(TAD)
using
SpliceAI
and
sequencing
data
from
diverse
cohorts,
including
551
early-onset
sporadic
dissection
cases
437
HTAD
probands
exome
sequencing,
57
pedigrees
whole
genome
select
clinical
panel
testing.
NCVAS
were
identified
syndromic
genes
such
as
FBN1,
SMAD3,
COL3A1,
intronic
FBN1
two
Marfan
syndrome
(MFS)
families.
Validation
Penn
Medicine
BioBank
UK
Biobank
showed
enrichment
HTAD-associated
among
dissections.
These
findings
suggest
are
an
underrecognized
contributor
TAD,
particularly
unsolved
MFS
cases,
highlighting
potential
advanced
prediction
tools
diagnostics.